ReviewJournal of oral and maxillofacial pathology : JOMFP
Prevalence of malignant melanoma in anatomical sites of the oral cavity: A meta-analysis.
Review in Journal of oral and maxillofacial pathology : JOMFP. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 23 citations in OpenAlex.
- Mendelian Randomization Unveils Poly(ADP-ribose) Polymerase 1 as Causal Plasma Protein Target in Melanoma, Integrated Multi-omics.Plastic and reconstructive surgery. Global open · 2026Article
- Effects of enoxaparin and aspirin on metastatic spread in a murine melanoma model.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Unveiling the Importance of Early Detection of Oral Mucosal Melanoma with Non-Invasive Imaging Techniques.Diagnostics (Basel, Switzerland) · 2026Review
- Recurrent Malignant Melanoma on the Tongue: A Case Report and Review of the Literature.Cancer reports (Hoboken, N.J.) · 2025Review
- Malignant Melanoma of the Tongue: A Scoping Review.Life (Basel, Switzerland) · 2025Review
- Article
- Challenges in the Diagnosis and Treatment of Oral Amelanotic Malignant Melanoma: A Case Report.Cureus · 2024Article
- A nuanced exploration delving into malignant melanomas occurring in unexpected and less common anatomical locations.Journal of family medicine and primary care · 2024Article
- Pigmented Oral Lesions: A Multicenter Study.European journal of dentistry · 2022Article
- Treatment Modalities of Recurrent Oral Mucosal Melanoma In Situ.Medicina (Kaunas, Lithuania) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oral malignant melanoma (OMM) is a very rare disease entity accounting <1% of all other melanomas. Till date, no comprehensive meta-analysis has been conducted regarding the prevalence of malignant melanoma in the oral cavity. Therefore, the present meta-analysis was conducted to update on the prevalence of malignant melanoma in anatomical sites of the oral cavity. Literature search was performed to congregate reports of last 10 years using databases, such as PubMed and ScienceDirect. The search strings used were "palate," "buccal," "gingiva," "gum," "maxillary," "mandibular," "lip," "tongue," "melanoma," "oral melanoma," "malignant melanoma," "prognosis," "risk factors," "noncutaneous" and "diagnosis" of OMM by combining terms using the Boolean operators. MedCalc 16.4.3 software was used for the analysis. "Random effects model" was used in the analysis due to significant heterogeneity in the studies. Proportion method was used to analyze the prevalence. Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed to report the analysis. Out of 130 studies screened, 19 were included in the meta-analysis and a total of 1323 patients were included. The median age of the patients was found to be 61.87 ± 7.78 years (confidence interval 53.8-67 years). All the screened studies showed significant heterogeneity in gender as well as tumor sites (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.